Skip to content

Regular research of "body surface-meridian-Zangfu correlation" of governor and conception vessels in treating uterus and brain-Randomized controlled trial of the treatment of Decreased ovarian reserve with conception vessels acupuncture

Regular research of "body surface-meridian-Zangfu correlation" of governor and conception vessels in treating uterus and brain-Randomized controlled trial of the treatment of Decreased ovarian reserve with conception vessels acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000882
Enrollment
Unknown
Registered
2024-12-28
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve

Interventions

Non-acupoint sham-acupuncture group:Sham acupuncture
Non-conception vessel acupoint group:Acupuncture
Conception vessel group:Acupuncture

Sponsors

Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) AMH<1.1 ng/ml; (2) Bilateral AFC<5-7; (3) 10 IU/L=FSH=25 IU/L; (4) 20 = age =45 years old; (5)Meeting the diagnostic criteria of DOR; (6) Informed consent was signed.

Exclusion criteria

Exclusion criteria: (1) Patients with endocrine related diseases affecting ovulation such as hyperprolactinemia polycystic ovary syndrome diabetes mellitus thyroid disease adrenal disease; (2)Pelvic lesions such as uterine fibroids adenomyosis ovarian tumors and unilateral or bilateral oophorectomy; (3) Clearly diagnosed autoimmune diseases such as systemic lupus erythematosus rheumatoid arthritis and antiphospholipid syndrome; (4) The use of hormone and metabolic drugs in the past 3 months affected the decision of the results; (5) Patients with cardiovascular brain liver and kidney dysfunction or severe mental illness; (6) Subjects who are participating in or have participated in another clinical trial within one month.

Design outcomes

Primary

MeasureTime frame
Basal antral follicle number;

Secondary

MeasureTime frame
Clinical abortion rate;Serum sex hormone levels;Clinical pregnancy rate;Serum anti-Mullerian hormone;Modified kupperman score;Clinical abortion rate;

Countries

China

Contacts

Public ContactYuxia Ma

Shandong University of Traditional Chinese Medicine

myxia1976@163.com186 5311 5177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026